Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Johnson

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Blood|November 25, 2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsAndrew P Mone, Peng Huang, Helene Pelicano, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
Blood Neoplasia|June 23, 2025
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myelomaSon Tran, Patrick Sipila, Melanie M Frigault, et al.
British Journal of Haematology|February 3, 2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaRosa Lapalombella, Aruna Gowda, Trupti Joshi, et al.
Biochemistry|June 1, 2018
Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated DegradationAlexandru D Buhimschi, Haley A Armstrong, Momar Toure, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 8, 2013
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissueYao Jiang, Jiang Wang, Darlene M Rozewski, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Blood|November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLShih-Shih Chen, Rainer Claus, David M Lucas, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Therapeutic Drug Monitoring|August 19, 2008
Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasmaQing Liu, Katherine L Farley, Amy J Johnson, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Blood|November 25, 2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsAndrew P Mone, Peng Huang, Helene Pelicano, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
Blood Neoplasia|June 23, 2025
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myelomaSon Tran, Patrick Sipila, Melanie M Frigault, et al.
British Journal of Haematology|February 3, 2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaRosa Lapalombella, Aruna Gowda, Trupti Joshi, et al.
Biochemistry|June 1, 2018
Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated DegradationAlexandru D Buhimschi, Haley A Armstrong, Momar Toure, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 8, 2013
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissueYao Jiang, Jiang Wang, Darlene M Rozewski, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Blood|November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLShih-Shih Chen, Rainer Claus, David M Lucas, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Therapeutic Drug Monitoring|August 19, 2008
Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasmaQing Liu, Katherine L Farley, Amy J Johnson, et al.
Pageof 13